140 Results
Sort By:
Published on June 19, 2023
New research by a team of Chinese, Canadian, and U.S. researchers has found that seeding newborn babies who are born via C-section with their mother’s vaginal bacteria improves neurodevelopment in the first months of life. The research, published last week in the journal Cell Host & Microbe, suggests this can…
Published on April 27, 2023
In a boost for the microbiome field, the U.S. FDA has approved Vowst (fecal microbiota spores, live-brpk). It is the first approved orally-administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI). The drug, from Seres Therapeutics and Nestlé Health Science, is expected to be available in June of this year.…
Published on November 2, 2022
According to a new study from the Yale University School of Medicine, genotoxic metabolites present in patients with inflammatory bowel disease (IBD) may play a role in the development of colorectal cancer. The authors of the study, published in the journal Science, discovered a family of genotoxins called indolimines, that…
Published on October 8, 2021
A research collaboration between British and Swiss scientists has shown in a preclinical study how bacteria in the gut can contribute to both the progression of advanced prostate cancer and developing resistance to hormone therapy. The findings are published in the journal Science in a paper titled, “Commensal bacteria promote endocrine resistance…
Published on February 5, 2021
Scientists from the NIH in collaboration with UPMC Hillman Cancer Center, reporting in Science, have demonstrated in a Phase II proof-of-principal study how some patients with advanced melanoma who haven’t responded to immune checkpoint inhibitor therapy, can be converted to immunotherapy responders by giving them a fecal microbiota transplant (FMT),…
Published on November 20, 2019
A collaborative team of researchers in France has demonstrated that an imbalance in gut microbiota, or dysbiosis, promotes the onset of colorectal cancer (CRC). The scientists, who have worked together as the Oncomix group since April 2016, showed that transplanting fecal microbiota from patients with colon cancer into mice caused…
Published on May 20, 2019
Data presented yesterday at the Digestive Disease Week (DDW) 2019 Conference by researchers from University of Texas, Galveston, suggest that the effects of coffee on our bowels seem to have little to do with caffeine. Findings from the study—which were presented at the conference yesterday in a presentation entitled “In…
Published on May 31, 2018
The chemical triclosan is used as an antimicrobial agent in more than 2000 consumer products, from toothpaste and cosmetics to kitchenware and toys. Studies in mice by a team of scientists in the U.S. and China have now linked short-term dietary exposure to triclosan with altered gut microbiota, colonic inflammation,…
Published on January 29, 2018
Benjamin Weinberg, M.D., of the Georgetown Lombardi Comprehensive Cancer Center has been awarded $125,000 by the Colorectal Cancer Alliance (CCA) to study differences in the colon microbiota between younger and older patients with colorectal cancer (CRC). The funding is part of CCA’s Chris4Life Research Program which focuses on young-onset CRC.…
Published on April 29, 2016
In a new study lead by scientists at the University of Minnesota and Nantes University Hospital in France, researchers showed that the bacteria in a patient’s gut might predict their risk for life-threatening blood infections following high-dose chemotherapy. Approximately 20,000 cancer patients receive high-dose chemotherapy each year in preparation for…
Published on June 12, 2024
Two sophisticated pills can provide a window into the condition of the digestive tract, potentially helping to personalized necessary treatments without resorting to invasive hospital tests. An AI-enabled ingestible pill used with wearable electronics can map gas levels in the gut and is described by Yasser Khan, PhD, and colleagues…
Published on June 5, 2024
A report published in 2023, estimates that over 40% of adults in the U.S. have obesity, defined as a body mass index (BMI) of over 30 kg/m2. While not everyone in this group is unwell, there is no doubt that obesity increases the risk of associated health conditions such as…
Published on May 22, 2024
Researchers at Washington University School of Medicine have found in a mouse study that a strain of the gut bacteria Ruminococcus gnavus can help enhance the effectiveness of cancer immunotherapy. The research, published in Science, points to the potential of using R. gnavus as a probiotic agent to improve the…
Published on April 29, 2024
The human gut bacteria Akkermansia muciniphila produces enzymes that are able to remove ABO blood group related antigens on the surface of red blood cells, which could help provide blood for those who need it in the absence of suitable donors. In a paper published in Nature Microbiology, the researchers…
Published on April 26, 2024
Researchers at the Francis Crick Institute, the National Cancer Institute (NCI) of the U.S. National Institutes of Health, and Aalborg University in Denmark have discovered that vitamin D can increase the amount of a certain type of gut bacteria, providing better immunity to cancer. Vitamin D is essential for human…